Joseph C. Papa
2020 - Valeant Pharmaceuticals International
In 2020, Joseph C. Papa earned a total compensation of $14.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,160,000 |
|---|---|
| Option Awards | $2,251,352 |
| Salary | $1,526,539 |
| Stock Awards | $8,127,907 |
| Other | $53,563 |
| Total | $14,119,361 |
Papa received $8.1M in stock awards, accounting for 58% of the total pay in 2020.
Papa also received $2.2M in non-equity incentive plan, $2.3M in option awards, $1.5M in salary and $53.6K in other compensation.
Rankings
In 2020, Joseph C. Papa's compensation ranked 460th out of 13,090 executives tracked by ExecPay. In other words, Papa earned more than 96.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 460 out of 13,090 | 97th |
Division Manufacturing | 158 out of 5,617 | 97th |
Major group Chemicals And Allied Products | 54 out of 2,248 | 98th |
Industry group Drugs | 48 out of 1,948 | 98th |
Industry Pharmaceutical Preparations | 34 out of 1,453 | 98th |
Source: SEC filing on May 2, 2022.
Papa's colleagues
We found four more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2020.
2020
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2020
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
2020
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2020
Sam Eldessouky
Valeant Pharmaceuticals International